Medacta International's MectaLIF Anterior Hybrid Interbody Fusion Device has been granted clearance by the FDA. The device, which will be added to the company's MectaLIF Cage product suite, is intended for restoring the native disc space height and lordosis, improving in situ stability and maintaining spinal balance in the long term.
Medacta's Anterior Hybrid Interbody Fusion Device wins FDA clearance
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.